OBJECTIVES: The purpose of this study was to investigate the effects of 6 weeks of
resistance training (RT) combined with aerobic training (AT) and Tirzepatide …

Aims Obesity and overweight are one of the main causes of some serious health problems
such as hepatic disease. Among none-drugs approach for overweight management …

OBJECTIVE: To study the effects of a 12-week continuous aerobic exercise program without
energy restriction on intrahepatic fat, indices of liver function (aspartate aminotransferase …

BACKGROUND Tirzepatide (TZP) promotes significant and clinically meaningful weight
loss. In a randomized blinded clinical trial in people with obesity undergoing caloric …

Objective. Limited studies have assessed the effect of moderate‐intensity continuous
aerobic exercise on hepatic fat content and visceral lipids in hepatic patients with diabesity …

Obesity is becoming more frequent and has several negative health impacts. Recent
advances in weight management strategies have primarily resided in pharmaceutical …

Background: Obesity increases the risk of multiple co-morbidities. Little is known about the
impact of this multimorbidity on weight reduction outcomes. This post hoc analysis of data …

Introduction: Fatty liver is a type of fat accumulation in liver cells that causing a malignant
process leading to the fibrosis of the liver tissue and cellular destruction if left unchecked …

Objectives: The aim of the present research was to investigate the effects of endurance
continuous training (ECT), circuit resistance training (CRT), high intensity interval training …

Background: A dual GIP and GLP-1 receptor agonist (RA) tirzepatide delivered robust body
weight (BW) loss in people with type 2 diabetes (T2D) and obesity in Phase 3 clinical trials …